Funds And Strategies
  • Business
  • Stocks
  • World News
  • Investing
  • Business
  • Stocks
  • World News
  • Investing

Funds And Strategies

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
Things are getting better at Boeing under CEO Ortberg, but can he keep it going?

Related Posts

Crypto Market Update: South Korea and Japan Set...

August 20, 2025

Joe Cavatoni: Gold Strong at Record Highs, What’s...

September 26, 2025

Biggest US Defense Contractors and ETFs in 2025

July 16, 2025

Uranium Energy’s Sweetwater Project Fast-Tracked Under Trump Initiative

August 7, 2025

Strong drilling targets identified next to high-grade gold-copper...

August 12, 2025

Brien Lundin: Gold at New US$3,000 Floor, Silver...

August 16, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (235)
    • Investing (1,174)
    • Stocks (206)
    • World News (648)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 fundsandstrategies.com | All Rights Reserved